HF
BLUE

HRT Financial’s bluebird bio BLUE Stock Holding History

HRT Financial’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,179
Closed -$81K – 2249
2024
Q1 		$81K Buy
+3,179
New +$81.5K ﹤0.01% 1879
2023
Q4 		– Sell
-6,505
Closed -$395K – 2341
2023
Q3 		$395K Buy
6,505
+850
+15% +$59.7K ﹤0.01% 1532
2023
Q2 		$372K Buy
+5,655
New +$414K ﹤0.01% 1505
2023
Q1 		– Sell
-18,127
Closed -$2.51M – 2517
2022
Q4 		$2.51M Buy
+18,127
New +$2.55M 0.04% 490
2022
Q3 		– Sell
-39,902
Closed -$3.3M – 2817
2022
Q2 		$3.3M Buy
+39,902
New +$3.09M 0.04% 379
2021
Q2 		– Sell
-1,443
Closed -$563K – 2863
2021
Q1 		$563K Buy
+1,443
New +$711K 0.01% 1678
2019
Q3 		– Sell
-291
Closed -$478K – 1395
2019
Q2 		$478K Buy
291
+130
+81% +$225K 0.03% 425
2019
Q1 		$327K Buy
+161
New +$284K 0.05% 273

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's BLUE Position: Q2 2024 in Review

HRT Financial sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 3,179 shares — an estimated $81K sold.

HRT Financial first reported a position in BLUE in Q1 2019 and held it in 8 quarters. The position peaked at $3.3M in Q2 2022. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.

  • HRT Financial reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 3,179 bluebird bio shares in Q2 2024, an estimated $81K.
  • HRT Financial first reported a position in bluebird bio in Q1 2019 and held it in 8 quarters.
  • HRT Financial's bluebird bio position peaked at $3.3M in Q2 2022.
  • 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.